Showing results (1771-1780 of 2,464) with videos related to
Sort By:
Pageof 247
Science Advances|December 23, 2020
RIPK3-mediated inflammation is a conserved β cell response to ER stressBingyuan Yang, Lisette A Maddison, Karolina E Zaborska, et al.Journal of Clinical Lipidology|September 17, 2022
Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid AssociationBruce A Warden, John R Guyton, Adrienne C Kovacs, et al.Computers and Biomedical Research, an International Journal|April 1, 1985
Development of a computerized infectious disease monitor (CIDM)R S Evans, R M Gardner, A R Bush, et al.Sports Health|November 2, 2013
Time to return to play after high ankle sprains in collegiate football players: a prediction modelBruce S Miller, Brian K Downie, Philip D Johnson, et al.Molecular Metabolism|February 7, 2018
TALK-1 reduces delta-cell endoplasmic reticulum and cytoplasmic calcium levels limiting somatostatin secretionNicholas C Vierra, Matthew T Dickerson, Kelli L Jordan, et al.Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Integrated Omics Approach to Delineate the Mechanisms of Doxorubicin-Induced CardiotoxicityMohamed S Dabour, Ibrahim Y Abdelgawad, Bushra Sadaf, et al.Diabetes, Obesity & Metabolism|August 4, 2004
Characteristics of US adults with the metabolic syndrome and therapeutic implicationsT A Jacobson, C C Case, S Roberts, et al.Archives of Internal Medicine|March 8, 2003
Risk for myopathy with statin therapy in high-risk patientsChristie M Ballantyne, Alberto Corsini, Michael H Davidson, et al.Biochemical Pharmacology|October 1, 1988
8-Substituted xanthines as antagonists at A1- and A2-adenosine receptorsK A Jacobson, R de la Cruz, R Schulick, et al.Bioorganic & Medicinal Chemistry Letters|November 18, 2005
Conversion of A3 adenosine receptor agonists into selective antagonists by modification of the 5'-ribofuran-uronamide moietyZhan-Guo Gao, Bhalchandra V Joshi, Athena M Klutz, et al.Pageof 247